US Material Events SEC 8-K Filings — March 23, 2026

23-03-2026

RenovoRx announced an oversubscribed $10M at-market private placement of ~10.6M common shares at $0.938/share (insiders at $1.029/share) plus milestone warrants for ~5.3M shares, anchored by life science institutional investors and participated in by senior management and board members. Proceeds will accelerate RenovoCath commercialization, which generated $900k in revenue over the first nine months of 2025 from initial purchase orders including repeat and new NCI-designated centers, and advance the Phase III TIGeR-PaC trial to full enrollment by mid-2026 with data in 2027. The financing supports goals of increasing revenue, reducing cash burn, and achieving cash-flow breakeven, with warrants tied to a $1.5M quarterly revenue milestone.

• ·Private placement priced at $0.938 per share for investors ($1.029 for executives/board); warrant exercise at $1.751 ($1.933 for executives/board), exercisable immediately, expire 30 days after $1.5M quarterly revenue announcement or March 30, 2029
• ·Expected closing March 20, 2026, subject to customary conditions
• ·First commercial RenovoCath purchase orders received December 2024
• ·RenovoCath has FDA clearance and Orphan Drug Designation (via IAG) for pancreatic and bile duct cancer

23-03-2026

Nortech Systems Incorporated entered into a new Credit and Security Agreement with Associated Bank, National Association on March 20, 2026, establishing a revolving credit facility of up to $15M (with $1.5M letter of credit sublimit) and a $2.2M term loan, replacing the prior facility set to mature in August 2026. The new facility and term loan mature in March 2029, bear interest at base rate or Term SOFR plus 2.00% (revolver) or 2.25% (term loan), and are secured by substantially all U.S. assets. It includes standard covenants such as a minimum Fixed Charge Coverage Ratio of 1.10:1.00 and typical events of default.

• ·Existing credit facility scheduled to mature in August 2026
• ·New facility secured by substantially all U.S. assets
• ·Financial covenant: Fixed Charge Coverage Ratio of at least 1.10 to 1.00 (EBITDA adjusted less unfunded capex over fixed charges)

23-03-2026

PMGC Holdings Inc. (ELAB) entered into Amendment No. 5 on March 17, 2026, to its consulting agreement with GB Capital Ltd (wholly owned by CEO/CFO/Director Graydon Bensler), setting the annual consultant fee at $300,000 effective January 1, 2026. The company also entered into a similar Amendment No. 5 with Northstrive Companies Inc. (wholly owned by Chairman Braeden Lichti), setting the annual fee at $360,000 effective the same date. These amendments restate fee provisions of prior agreements originally dated October 25, 2024, with no other changes.

• ·Original consulting agreements dated October 25, 2024
• ·Prior amendments dated April 3, 2025; August 12, 2025; October 16, 2025
• ·Filing date: March 23, 2026

23-03-2026

Verde Clean Fuels, Inc. appointed George Burdette, its current CFO since October 2024, as new CEO, succeeding Ernie Miller who is stepping down to pursue other opportunities but will remain as a senior advisor. The company engaged Roth Capital Partners as a financial advisor to evaluate strategic alternatives, including potential merger, sale, or other transactions involving its STG+® technology, as part of ongoing restructuring and cost reduction initiatives. While positioned as a step to maximize shareholder value through capital-lite opportunities, the process has no set timetable and no assurance of any transaction.

• ·George Burdette previously served as CFO of Arbor Renewable Gas and Itafos, and head of project finance at First Solar.
• ·No binding agreements entered for strategic alternatives; company does not intend to disclose developments unless required.
• ·Announcement dated March 20, 2026; SEC filing March 23, 2026.

23-03-2026

Ormat Technologies, Inc. announced a proposed private offering of $600M aggregate principal amount of Series A Convertible Senior Notes due 2031 and $150M of Series B Convertible Senior Notes due 2031, with options for initial purchasers to buy up to an additional $90M Series A and $22.5M Series B. Net proceeds, along with $25M cash on hand, will fund repurchase of a portion of its outstanding 2.50% convertible senior notes due 2027 via private negotiations, up to $25M in common stock repurchases to offset dilution, and general corporate purposes. The notes are unsecured senior obligations with semiannual interest payments starting September 15, 2026, maturing March 15, 2031.

• ·Series B Notes optional repurchase date: March 15, 2027 at 100% principal plus accrued interest.
• ·Notes redeemable at company's option on or after March 20, 2029, if stock price >=130% of conversion price for specified period.
• ·Conversion prior to November 15, 2030 under certain circumstances; cash, shares, or combination for excess over principal.
• ·Offerings to qualified institutional buyers under Rule 144A; unregistered under Securities Act.

23-03-2026

1606 Corp. amended and restated a promissory note to its former CEO Gregory Lambrecht, increasing the principal from $1.22M (issued Nov 1, 2024) to $1.89M effective Dec 31, 2025, due to additional loans provided by him. The note matures Dec 31, 2025 and is convertible at the holder's option into common stock at a 25% discount to the closing bid price, subject to a 9.99% beneficial ownership limit, creating a direct financial obligation with potential shareholder dilution.

• ·Board of directors approved the issuance on March 17, 2026.
• ·Filed as Exhibit 4.1: Amended and Restated Promissory Note dated December 31, 2025.

23-03-2026

Cardinal Health appointed Patricia A. Hemingway Hall as Board Chair effective immediately, succeeding Gregory B. Kenny upon his retirement; Kenny had served on the Board since 2007 and as Chairman since 2018. CEO Jason Hollar expressed gratitude for Kenny's leadership during periods of transformation and confidence in Hemingway Hall's continuation of strong governance. The company reaffirmed confidence in its fiscal 2026 outlook ahead of third quarter earnings release on April 30.

• ·Ms. Hemingway Hall served on the Board since 2013 and as Chair of the Governance and Sustainability Committee for nearly seven years.
• ·Former CEO role of Ms. Hemingway Hall: President and Chief Executive Officer of Health Care Service Corporation.
• ·Third quarter fiscal 2026 earnings release scheduled for April 30, 2026.

23-03-2026

Ingredion Incorporated announced the retirement of director Gregory B. Kenny effective March 23, 2026, after serving since 2005, stating it was not due to any disagreement with company operations, policies, or practices. The Board elected Siobhán Talbot, former CEO of Glanbia plc, as an independent director effective April 1, 2026; she will receive standard non-management director compensation including cash and equity retainers.

• ·Gregory B. Kenny informed company of retirement decision on March 20, 2026.
• ·Siobhán Talbot, age 62, served Glanbia plc for 31 years, including as CEO from November 2013 to December 2023.
• ·Talbot serves on CRH plc board and audit committee.
• ·Director compensation details in proxy statement filed April 9, 2025.

23-03-2026

Coeur Mining completed its acquisition of New Gold Inc. on March 20, 2026, significantly boosting 2026 consolidated production guidance to 680,000-815,000 oz gold (80% increase from 419,046 oz in 2025), 18.7-21.9M oz silver (from 17.9M oz), and 50-65M lbs copper, incorporating nine months from New Afton and Rainy River. The company authorized a $750M share repurchase program, an inaugural $0.02/share semiannual dividend starting Q2 2026, and a new $1.0B revolving credit facility replacing the prior $400M facility. Updated reserves and resources for New Afton and Rainy River support mine life extensions to 2032 and 2035, respectively, with strong projected free cash flows.

• ·New Afton 2025 reserves: 36.2M tonnes (780k oz gold, 2.1M oz silver, 591M lbs copper)
• ·Rainy River 2025 reserves: 2.2M oz gold, 5.6M oz silver
• ·New Afton K-Zone M&I resources: 47.6M tonnes (715k oz gold, 2.9M oz silver, 606M lbs copper)
• ·2026 cash income and mining taxes: $475-600M
• ·Effective tax rate: 30-36%

23-03-2026

State Street Corporation elected Susan Gordon as an independent director on March 19, 2026, with appointments to the Examining and Audit Committee and the Technology and Operations Committee. She will receive a pro rata share of the 2025-2026 $110,000 annual retainer and $235,000 common stock retainer, based on the NYSE closing price on the election date. There are no related arrangements or understandings, and she will enter into a standard indemnification agreement.

• ·Election disclosed in Form 8-K filed March 23, 2026, referencing Exhibits 10.9 and 10.11A from 2025 10-K.
• ·No arrangements or understandings pursuant to Ms. Gordon's election.

23-03-2026

On March 17, 2026, Jennifer Jarrett notified Arcus Biosciences, Inc. of her resignation as Chief Operating Officer, effective March 30, 2026, stating it was not due to any disagreement with the company's operations, policies, or practices. The company entered into a separation agreement under which Ms. Jarrett will provide periodic advisory services through June 30, 2026, in exchange for an extension of her post-termination vested option exercise period to 12 months.

• ·Separation agreement contains a standard release of claims.
• ·Full separation agreement to be filed with the next Form 10-Q.

23-03-2026

Fathom Holdings Inc. and its subsidiaries (E4:9 Holdings LLC, IntelliAgent LLC, Fathom Realty Holdings LLC, and Verus Holdings Inc.) entered into a Security Agreement dated March 18, 2026, with Bed Bath & Beyond, Inc., granting a continuing security interest in their collateral to secure a subordinated secured promissory note with an initial principal of $2M. The agreement includes covenants on collateral maintenance, no dispositions without consent, and remedies upon default. No financial performance metrics or period-over-period comparisons are disclosed.

• ·Agreement filed as EX-10.1 with SEC 8-K on March 23, 2026, covering Items 1.01, 2.03, 9.01.
• ·Debtors' chief executive office and collateral location: 2000 Regency Parkway Drive, Suite 300, Cary, NC 27518.
• ·Requires 10 days' prior written notice for changes in name, location, or mergers.

23-03-2026

Dollar Tree, Inc. entered into a new Credit Agreement dated March 19, 2026, for a term loan facility with lenders listed on Schedule I, Bank of America, N.A. as Agent, and BofA Securities, Inc. as Sole Lead Arranger and Sole Bookrunner. The agreement outlines term loan commitments with borrowing minimums of $1M and multiples starting at $250k, variable Applicable Margins starting at 0% for Base Rate Loans and 1% for Term SOFR Rate Loans (adjustable based on leverage ratio or public debt rating), and a Base Rate floor of 1%. No specific total commitment amount or prior facility details are provided for comparison, resulting in no observable changes.

• ·Leverage Ratio pricing tiers: Level I ≤1.5 to 1.0; Level II ≤2.0 to 1.0; Level III ≤2.5 to 1.0; Level IV ≤3.0 to 1.0; Level V >3.0 to 1.0.
• ·Applicable Margin for Base Rate Loans ranges from 0.000% (Levels I-III) to 0.375% (Level V).
• ·Agreement includes standard covenants, events of default, and representations typical for term loan facilities.

23-03-2026

Janus Living, Inc. entered into the Amended and Restated Operating Agreement for its operating partnership, Janus Living OP, LLC, effective March 17, 2026, governing membership interests, capital contributions, distributions, management, allocations, transfers, and LTIP units. The LLC was originally formed on December 22, 2025, by Healthpeak OP, LLC, with amendments on January 22, 2026, for a name change and on January 23, 2026, for transfer of ownership interest to Janus Living, Inc. No financial metrics, performance changes, or quantitative impacts are disclosed in the agreement.

• ·Original formation date: December 22, 2025
• ·Prior amendments: January 22, 2026 (name change); January 23, 2026 (ownership transfer)
• ·Agreement includes provisions for LTIP Units, equity incentive plans, and REIT compliance (e.g., Adjustment Factor tied to Class A-1 REIT Shares)

23-03-2026

VRM MSP Recovery Partners, LLC, managed by Virage Capital Management LP, provided a one-time $75,000 advance to MSP Recovery, LLC to support its accounts payables, conditional on immediate reimbursement from future loan proceeds (excluding short-term financing from Hazel Partners Holdings, LLC) and agreement to appoint Nader Tavakoli as Chief Restructuring Officer. This follows multiple prior consents allowing MSP Recovery to use recovery proceeds otherwise distributable to the Company. The agreement highlights ongoing liquidity pressures at MSP Recovery, with references to potential debtor-in-possession financing under Chapter 11.

• ·Prior consents via email/letters dated September 5, 2025; October 16, 2025; November 14, 2025; November 26, 2025; December 19, 2025; February 19, 2026
• ·LLC Agreement amendments: August 1, 2020; December 1, 2020; March 9, 2022; July 28, 2023; November 13, 2023

23-03-2026

BioAtla, Inc. stockholders overwhelmingly approved the Merger Proposal for a 1-for-50 share consolidation (Merger with wholly-owned subsidiary BA Merger Sub, Inc.) at the reconvened Special Meeting on March 23, 2026, with 49.2 million votes in favor out of 50.7 million shares present (68% quorum). Amid challenges including no bonuses earned for 2025 due to missed financial milestones and no 2026 salary increases, the Compensation Committee approved retention bonuses for CFO Christian Vasquez ($37K Milestone #1, $149K #2) and CMO Eric Sievers ($53K #1, $212K #2), while the Board approved $450K for CEO Jay Short, all contingent on financial/capital milestones by May 31 and/or August 31, 2026.

• ·Retention bonuses on sliding scale: 80-120% of target based on milestone achievement (±20% threshold); no payout if >20% miss.
• ·Milestone #1 payouts by June 30, 2026; Milestone #2 and Short bonus by September 30, 2026; requires employment in good standing.
• ·Merger effective date to be announced at least two business days prior, subject to Nasdaq notice periods.

23-03-2026

General Motors Company and General Motors Financial Company, Inc. entered into the Eighth Amended and Restated 364-Day Revolving Credit Agreement dated March 23, 2026, amending and restating the prior Seventh Amended and Restated agreement from March 25, 2025. The facility involves multiple lenders, with JPMorgan Chase Bank, N.A. as Administrative Agent and Citibank, N.A. as Syndication Agent, along with various joint lead arrangers and bookrunners. No specific commitment amounts, pricing grids, or changes in terms are detailed in the filing excerpt.

• ·Filing Type: 8-K, Items: 1.01, 2.03, 9.01
• ·Previous credit agreement effective date: March 25, 2025
• ·Schedules include Commitments (1.1A), Applicable Pricing Grid (1.1C), but details redacted or not provided

23-03-2026

On March 20, 2026, Robert W. Dudley, a member of the Board of Directors of Freeport-McMoRan Inc., notified the Lead Independent Director and Chairman that he will not stand for re-election at the company's 2026 annual meeting of stockholders. Mr. Dudley will continue serving the remainder of his current term, which ends at that meeting. The decision was explicitly stated not to be due to any disagreement with the company.

23-03-2026

Unusual Machines, Inc. entered into a Placement Agency Agreement on March 19, 2026, with Dominari Securities LLC and JonesTrading Institutional Services LLC for a confidentially marketed public offering of 8,823,529 shares of common stock at $17.00 per share, generating gross proceeds of approximately $150 million before fees and expenses. The offering closed on March 23, 2026, with net proceeds allocated to acquiring additional inventory, general corporate purposes, and working capital. No comparative period data or negative performance metrics were reported.

• ·Placement Agents: Dominari Securities LLC and JonesTrading Institutional Services LLC
• ·Offering pursuant to effective shelf registration on Form S-3 (No. 333-286413), declared effective April 21, 2025
• ·Preliminary prospectus supplement filed March 19, 2026; final prospectus supplement filed March 23, 2026

23-03-2026

General Motors Company and General Motors Financial Company, Inc. entered into the Eighth Amended and Restated 364-Day Revolving Credit Agreement dated March 23, 2026, amending and restating the prior Seventh Amended and Restated agreement from March 25, 2025. The facility involves multiple lenders led by JPMorgan Chase Bank, N.A. as Administrative Agent and Citibank, N.A. as Syndication Agent, with terms including commitments detailed in Schedule 1.1A (not specified in excerpt) and standard covenants such as minimum liquidity and indebtedness restrictions. No quantitative changes or performance metrics are disclosed in the filing.

• ·Agreement replaces Seventh Amended and Restated 364-Day Revolving Credit Agreement dated March 25, 2025.
• ·References related facilities: Sixth Amended and Restated Three Year Revolving Credit Agreement and Fifth Amended and Restated Five Year Revolving Credit Agreement, both dated March 25, 2025.
• ·Covenants include Minimum Liquidity (Section 7.1), Indebtedness limits (Section 7.2), and Asset Sale Restrictions (Section 7.3).

23-03-2026

Everest Group, Ltd. (NYSE: EG) announced a definitive agreement to sell its Canadian Retail Insurance operations, Everest Insurance Company of Canada, to The Wawanesa Mutual Insurance Company, marking a key step in its strategic repositioning and exit from Commercial Retail Insurance operations following the 2025 sale of renewal rights to AIG. The transaction is expected to deliver compelling value to shareholders and transition employees to Wawanesa, with closure anticipated in the second half of 2026 subject to regulatory approvals. No financial terms of the deal were disclosed.

• ·Transaction advisors: Ardea Partners LP (exclusive financial advisor to Everest), Debevoise & Plimpton LLP and Stikeman Elliott LLP (legal advisors to Everest); TD Securities (exclusive financial advisor to Wawanesa), Torys LLP (legal advisor to Wawanesa)
• ·Everest common stock (NYSE: EG) is a component of the S&P 500 index

23-03-2026

Arbor Realty Trust, Inc. (NYSE: ABR) closed a $762.6M commercial real estate mortgage loan securitization, issuing approximately $674.0M in investment grade-rated notes while retaining $88.6M in subordinate interests. The collateral includes $100M capacity for additional loans over up to 180 days, with Notes carrying a weighted average spread of 1.73% over Term SOFR and a reinvestment period of about 2.5 years. Proceeds will repay credit facility borrowings, cover transaction expenses, and fund future loans and investments.

• ·Reinvestment period of approximately two years and six months for principal proceeds.
• ·Notes issued via private placement under an indenture, secured by real estate assets primarily first mortgage bridge loans.
• ·Certain Notes rated by Fitch Ratings, Inc.; all except most subordinate class rated by Kroll Bond Rating Agency, LLC.
• ·Arbor expects to account for the securitization as a balance sheet financing.

23-03-2026

Sonoco Products Company entered into a $300M Term Credit Agreement on March 23, 2026, with Wells Fargo Bank, National Association as Administrative Agent and Wells Fargo Securities, LLC as lead arranger, providing aggregate commitments of $300M for loans to the borrower. Interest rates for Term SOFR/Daily Simple SOFR Loans range from 0.850% (Pricing Level I) to 1.100% (Pricing Level III) based on S&P/Moody's debt ratings, with a ticking fee of 0.125% per annum initially, increasing to 0.250% after 91 days. No performance declines or flat metrics are mentioned in the agreement.

• ·Audited Financial Statements reference consolidated balance sheet as of December 31, 2025.
• ·Base Rate floor of 1.00%.
• ·Debt Ratings determine pricing levels: Level I (≥ BBB/Baa2), II (BBB-/Baa3), III (≤ BB+/Ba1).

23-03-2026

Waters Corporation's subsidiary, Augusta SpinCo Corporation, completed a $3.5B public offering of senior notes consisting of $650M 4.321% due 2027, $600M 4.398% due 2029, $750M 4.656% due 2031, $750M 4.945% due 2033, and $750M 5.245% due 2036, fully guaranteed by Waters and certain subsidiaries. The notes were issued under an indenture with covenants limiting liens, sale-leasebacks, and mergers, and include customary redemption and change of control repurchase rights. Net proceeds, along with cash on hand, will repay $3.5B of a delayed draw term loan from February 2026.

• ·Notes redeemable at Issuer's option (except 2027 Notes) at prices per Indenture terms.
• ·Change of control triggering events allow holders to require repurchase at 101% of principal plus accrued interest.
• ·Indenture covenants limit liens, sale-leaseback transactions, and require conditions for mergers.
• ·Underwriting agreement dated March 17, 2026, with listed representatives.

23-03-2026

Healthpeak OP, LLC, a subsidiary of Healthpeak Properties, Inc., entered into Amendment No. 5 to its Term Loan Agreement dated August 22, 2022, effective March 23, 2026, increasing the aggregate principal amount cap for Term A-1, A-2, A-3, A-4 Loans and additional Incremental Term Loans to $2B. The amendment introduces a new Term A-4 Facility with commitments from Term A-4 Lenders, administered by Bank of America, N.A. No declines, flat performance, or adverse financial metrics were reported.

• ·Previous amendments: Consent and Amendment No. 1 (Feb 10, 2023), No. 2 (Mar 1, 2024), No. 3 (Dec 9, 2024), No. 4 (Oct 3, 2025)
• ·Effectiveness subject to conditions including legal opinions, certifications, no Default/Event of Default, KYC compliance, and payment of fees

23-03-2026

On March 23, 2026, Charging Robotics Inc. entered into an Earn-Out Milestone Amendment Agreement with holders of Milestone Warrants originally issued to Xylo Technologies Ltd., extending the deadline for achieving three earn-out milestones from December 31, 2025, to December 31, 2026, amid ongoing security considerations in Israel. The warrants cover an aggregate of 6,150,000 shares, with vesting contingent on all milestones being met by the new deadline and no partial vesting allowed. The amendment also modifies certain milestone terms without other changes to the underlying Securities Exchange Agreement.

• ·Milestones: (a) Inhouse demonstration of wireless charging system for EV in automated parking; (b) Conditional PO for 1st system for automatic car parks; (c) Commercial agreement for pilot with board-approved organization.
• ·Milestone Warrants issued pursuant to Securities Exchange Agreement dated March 28, 2023.
• ·Shares issuable upon exercise not registered under Securities Act, relying on Section 4(a)(2) and/or Rule 506 exemption.

23-03-2026

BitGo Holdings, Inc. disclosed the determination of Fiscal Year 2025 discretionary cash bonuses for its Named Executive Officers via an updated Summary Compensation Table, with total compensation ranging from $474,806 for CFO Edward Reginelli to $1,069,000 for Chief Revenue Officer Chen Fang. The Compensation Committee approved these on March 18, 2026, following the January 2026 IPO. Additionally, CFO Reginelli received a special $500,000 cash bonus and RSUs for 47,125 shares vesting over four years.

• ·All Other Compensation includes 401(k) matching: $14,000 for Reginelli and Fang, $13,309 for Mettler, $8,667 for Horowitz.
• ·RSU grant to CFO effective March 28, 2026, vests 25% after one year, then monthly over three years.
• ·No stock or option awards recognized in table for most NEOs except Mettler's options.

23-03-2026

Empery Digital Inc. announced a $25M registered direct offering of 4.638M shares and warrants at $5.39 per share (103% of NAV), with closing expected on March 24, 2026, and intends to use proceeds plus cash on hand to reduce outstanding debt by $40M via full repayment of $50M Repo Facility and partial use of $100M credit facility with Two Prime. The company has repurchased 22.35M shares under its $200M repurchase program at an average $5.92/share as of March 20, 2026, resulting in 33.71M shares outstanding post-offering and potential warrant exercises. It sold 63 BTC for $4.6M in the week ending March 20 and holds 3,439 BTC.

• ·Warrants exercisable immediately and expire four years from issuance.
• ·No placement agent engaged; no fees paid.
• ·Shelf registration on Form S-3 effective September 19, 2025.

23-03-2026

On March 19, 2026, Virtuix Holdings Inc. (VTIX) appointed Cameron Slayter as Chief Product Officer, effective immediately, promoting him from Creative Director with an annual base salary of $175,000. The Board also changed Lauren Premo’s title to Chief Marketing Officer from Head of Marketing, with no change to her compensation. These internal promotions highlight continuity in leadership with no reported family relationships or material transactions involving the appointees.

• ·Cameron Slayter, age 33, has been with the company since 2014, leading game development and UI/UX design.
• ·No family relationships between appointees and any director or executive officer.
• ·No transactions requiring disclosure under Item 404(a) of Regulation S-K.

23-03-2026

Concentrix Receivables, Inc. (Borrower) and Concentrix Corporation (Servicer) entered into the Sixth Amendment to the Receivables Financing Agreement on March 20, 2026, amending the original agreement dated October 30, 2020, with key lenders including PNC Bank (Administrative Agent), TD Bank, Wells Fargo, and MUFG Bank. The amendment is subject to conditions precedent such as executed documents, fee letters, certificates, and legal opinions, and reaffirms no Events of Default or Termination Date occurrence. All prior covenants and the Performance Guaranty remain in full force and effect.

• ·Amendment effective upon satisfaction of conditions including Fourth Amended and Restated Fee Letter and updated Secretary’s Certificates.
• ·Governed by laws of the State of New York.

23-03-2026

Mesa Laboratories, Inc. announced the departure of Gary Owens as President and Chief Executive Officer, effective on or about April 13, 2026, following a Retention and Transition Agreement signed on March 20, 2026, under which he will remain in a non-executive capacity until the Separation Date of June 22, 2026. Owens also resigned from the Board of Directors on March 20, 2026, with no disagreements on company matters. Upon separation, he is entitled to severance pay, benefits for a 'without cause' termination, and a pro-rated portion of his June 15, 2025 performance stock unit award.

• ·Departure initially announced on March 9, 2026
• ·Resignation from Board effective March 20, 2026, not due to any disagreement
• ·PSU award vests at lower of target or actual performance for period ending June 15, 2025

23-03-2026

Guardian Pharmacy Services, Inc. entered into Stock Purchase Agreements on March 18, 2026, to repurchase up to 1,833,344 shares of Class A common stock using proceeds from public offerings, and consummated an underwritten public offering on March 20, 2026, of 6,900,000 shares at $31.00 per share (5,880,000 from selling stockholders and 1,020,000 newly issued by the company, with proceeds used to repurchase and cancel an equivalent number of shares, resulting in no change to outstanding shares). The offering was non-dilutive but led to the loss of controlled company status under NYSE rules, requiring the establishment of an independent Nominating and Governance Committee. Selling stockholders, including Bindley Capital Partners I, LLC and others, are subject to a lock-up until the later of June 30, 2026, or 180 days after the latest underwriting agreement.

• ·Stock Purchase Agreements executed March 18, 2026; Offering consummated March 20, 2026; Filing dated March 23, 2026.
• ·Company qualified as controlled company prior to Offering due to majority voting power held by selling stockholders; now subject to full NYSE governance requirements with transition periods.

23-03-2026

Resolute Holdings Management, Inc. entered into an Incremental Amendment dated March 18, 2026, to its existing Credit Agreement originally dated February 20, 2026, increasing the Revolving Commitments by $10M through Additional Revolving Commitments provided by Increasing Lenders. The amendment requires satisfaction of conditions precedent including certifications of no Defaults, compliance with covenants on a pro forma basis, legal opinions, and a solvency certificate, with no outstanding Revolving Loans affected in type or interest periods. JPMorgan Chase Bank, N.A. acts as Administrative Agent and Increasing Lender, with Bank of America, N.A. as an Amendment Lender.

• ·Amendment filed as 8-K on March 23, 2026, covering Items 1.01, 2.03, 9.01.
• ·Waiver of certain requirements under Section 2.09(g)(ii) and penultimate sentence of Section 2.09(g) by Required Lenders.
• ·Governing law: State of New York; includes jury trial waiver.

23-03-2026

Perrigo Company PLC entered into an Amended and Restated Credit Agreement dated March 20, 2026, with Perrigo Investments, LLC as the initial borrower and other subsidiaries as designated borrowers, establishing a revolving facility (CUSIP: 71429TAG5) and Term B Facility (CUSIP: 71429TAF7) under Deal CUSIP 71429TAA8. JPMorgan Chase Bank, N.A. serves as Administrative Agent and Collateral Agent, with participation from multiple banks including Wells Fargo, BofA Securities, Goldman Sachs, Morgan Stanley, Mizuho, HSBC, ING, and BNP Paribas as arrangers, bookrunners, syndication agents, and documentation agents. No specific facility sizes, rates, or other financial terms were detailed in the provided filing content.

• ·Filing Date: March 23, 2026
• ·Agreement Effective Date: March 20, 2026
• ·SEC Items: 1.01, 2.03, 9.01
• ·Deal CUSIP Number: 71429TAA8

23-03-2026

Stoneridge, Inc. (SRI) announced that Matt Horvath will resign as Chief Financial Officer and Treasurer effective March 31, 2026, as previously disclosed. The Board elected Robert J. Hartman, Jr., the Company's 27-year veteran and current Chief Accounting Officer, as Interim CFO and Treasurer effective the same date, while conducting a search for a permanent replacement. No family relationships or material conflicts exist with Mr. Hartman.

• ·Event reported on March 17, 2026; filing dated March 23, 2026.
• ·Mr. Hartman, age 59, has over 27 years at Stoneridge in accounting, finance, and internal audit.
• ·No arrangements or understandings with other persons for appointment; no interests under Item 404(a) of Regulation S-K.

23-03-2026

SiriusPoint Ltd reported the departure of Rob Gibbs, President & Chief Executive Officer of SiriusPoint International Insurance Corporation (publ), with his last day of employment on April 30, 2026. Under the March 17, 2026 Settlement Agreement, Gibbs will receive a total severance payment of 401,700 GBP in 12 monthly installments, continuation of private medical insurance through April 30, 2027, and life assurance through December 31, 2026 plus 3,000 GBP in lieu thereafter, but he is not entitled to a 2025 bonus. Gibbs remains bound by post-employment confidentiality, non-disparagement, non-compete, and non-solicitation obligations.

• ·Severance payment subject to income tax withholdings and National Insurance contributions.
• ·Outstanding equity awards treated per applicable agreements, as modified by Settlement Agreement.
• ·Settlement conditioned on execution and non-revocation of general release of claims.
• ·Announcement of departure via prior 8-K filed March 16, 2026.

23-03-2026

Robert N. Mackay, a director of Customers Bancorp, Inc. and its subsidiary Customers Bank since 2022, informed the company on March 20, 2026, that he intends to retire and not stand for reelection at the 2026 Annual Meeting of Shareholders to focus on his role as CEO of a global regulatory technology company. His retirement will become effective immediately following the meeting, and the decision is unrelated to any disagreements with the company's or bank's operations, policies, or practices.

• ·Mr. Mackay currently serves on the Company’s Directors Risk & Compliance Committee and Leadership Development & Compensation Committee.

23-03-2026

Sutro Biopharma reported FY2025 revenue of $102.5 million, up 65% YoY from $62.0 million driven by Astellas and Ipsen collaborations, while R&D expenses fell 34% to $166.4 million and total operating expenses declined 13% to $260.9 million including $53.4 million in restructuring costs. Net loss improved to $191.1 million from $227.5 million YoY, but cash position dropped sharply to $141.4 million from $316.9 million, offset by a $110 million equity raise extending runway to at least Q2 2028. Pipeline progressed with STRO-004 Phase 1 dosing completed in three cohorts (data mid-2026), STRO-227 IND targeted for 2026, and Astellas' TROP2 iADC entering clinic.

• ·Restructuring costs: $53.4M in FY2025 (total cash payments estimated $4.1M-$4.3M)
• ·STRO-004 preclinical HNSTD: 50 mg/kg (clinical start: 1 mg/kg)
• ·AACR 2026 presentations scheduled April 17-22 including oral on STRO-004 and ASP2998
• ·Stockholders' equity shifted to deficit of $132.5M as of Dec 31, 2025 from $44.6M surplus

23-03-2026

Element Solutions Inc announced that Sir Martin E. Franklin, Executive Chairman of the Board, plans to step down and will not seek re-election at the 2026 Annual Meeting of Stockholders. Ian G.H. Ashken, a founding Board director since 2013 and Chair of the Nominating and Policies Committee, has been appointed Non-Executive Chairman effective at the Annual Meeting. Franklin will remain a substantial shareholder and continue as a counselor to CEO Ben Gliklich.

• ·Announcement dated March 23, 2026
• ·Ashken has been a founding director since 2013
• ·Franklin has partnered with CEO Gliklich for more than 12 years

23-03-2026

Hilary A. Schneider decided to depart from Sleep Number Corporation's Board of Directors upon the conclusion of the 2026 Annual Meeting of Shareholders due to new board service limitations from her recent appointment as Chief Executive Officer of SimpliSafe. The departure is not the result of any disagreement with the Company on operations, policies, or practices. The Company expressed thanks for her leadership and contributions.

• ·Event date: March 17, 2026
• ·Filing date: March 23, 2026

23-03-2026

On March 18, 2026, Intelligent Bio Solutions Inc. granted time-vesting restricted stock awards of 9,150 shares each to CEO Harry Simeonidis and CFO Spiro Sakiris (vesting after 48 months), plus performance-vesting awards of 21,350 shares each tied to clinical, regulatory, and commercial milestones; non-employee directors received an aggregate 20,000 time-vesting shares (vesting after 12 months), and non-executive employees received 10,500 time-vesting and 24,500 performance-vesting shares. As of March 23, 2026, the company had 2,001,173 shares of common stock outstanding following these grants and warrant exercises. The company also filed a 2026 ATM Supplement enabling up to $3.97M in additional common stock sales under its existing ATM Agreement.

• ·Performance-vesting shares subject to milestones: 30% upon clinical trial achievement (post-1 year), 40% upon FDA regulatory submission (post-1 year), 30% upon commercial supply/sales milestone (post-1 year); unachieved portions forfeit after 10 years.
• ·Awards include dividend rights on unvested shares (paid upon vesting) and are subject to clawback policy.
• ·ATM Agreement originally dated September 18, 2024; Registration Statement effective September 10, 2025 (File No. 333-286489).

23-03-2026

Dominari Holdings Inc. amended the employment agreements of CEO Anthony Hayes and President Kyle Wool on March 20, 2026 (effective immediately and retroactive to January 1, 2026), replacing annual bonus provisions with performance-based quarterly bonuses and a Net Revenue Bonus equal to 15% of net investment banking fees and alternate revenues from Dominari Securities LLC and other opportunities. In exchange, the Company issued 3,000,000 shares of common stock to each executive, as approved by shareholders on March 4, 2026. No other terms of the agreements were changed.

• ·Amendments replace Section 4(b) of original employment agreements dated June 28, 2022 (Hayes) and October 12, 2022 (Wool), most recently amended June 24, 2025
• ·Shares issued pursuant to registration statement on Form S-8
• ·Quarterly bonuses determined by Compensation Committee based on corporate performance and shareholder value creation

23-03-2026

Crown Holdings, Inc. entered into a Second Amended and Restated Credit Agreement on March 17, 2026, amending and restating the prior agreement from April 7, 2017, providing for a $800M Dollar Revolving Facility, $800M Multicurrency Revolving Facility, $50M Canadian Revolving Facility, $1,175M Term Loan A Facility, and €499.5M Term Euro Facility, all maturing March 17, 2031. The facilities bear interest at SOFR plus 1.25% at closing (adjustable by up to 0.25% based on Total Leverage Ratio) and are secured by equity interests in U.S. and certain non-U.S. subsidiaries, with guarantees from parent guarantors and subsidiaries. Proceeds were used to refinance prior indebtedness, pay transaction costs, and for general corporate purposes; the agreement includes affirmative/negative covenants, a maximum leverage ratio requirement, and standard events of default.

• ·Facilities secured by equity interests in U.S. subsidiaries and certain non-U.S. subsidiaries (with exceptions).
• ·Borrowings guaranteed by Parent Guarantors, Company, and direct/indirect U.S. subsidiaries and certain non-U.S. subsidiaries.
• ·Mandatory prepayments required under certain circumstances.

23-03-2026

Crawford & Company appointed W. Bruce Swain Jr. as permanent President & CEO effective March 23, 2026, succeeding his interim role since January 1, 2026, due to his 30+ years of experience including 19 years as CFO. Jesse Crawford Sr., a board member since 1986, announced he will not stand for reelection at the May 14, 2026 Annual Shareholder Meeting and will transition to honorary board member, honoring his 40 years of service. The board expressed full confidence in Swain's leadership to advance the company's strategy.

• ·Swain served 19 years as CFO.
• ·Crawford family leadership spans generations, with Jesse Crawford Sr. as second generation.
• ·Company headquartered at 5335 Triangle Parkway NW, Peachtree Corners, GA 30092.

23-03-2026

Skillz Inc. extended CFO Gaetano Franceschi's departure date from March 31, 2026, to the earlier of October 1, 2026, or a mutually agreed date following the appointment of a permanent successor. Mr. Franceschi will continue receiving compensation per prior agreements and is eligible for a $300,000 retention payment (subject to service through October 1) plus a discretionary bonus up to $300,000 based on performance and transition success. The company is actively searching for a permanent CFO successor.

• ·Side Letter Amendment approved by Board and Compensation Committee on March 19, 2026.
• ·References prior Transition and Separation Agreement dated December 17, 2025, and Side Letter from December 30, 2025.
• ·Company address: 6625 Badura Avenue, Las Vegas, Nevada 89118.

23-03-2026

On March 19, 2026, the Board of Directors of Newsmax Inc. appointed David Evans as a member to fill an existing vacancy, effective immediately, and also to the Audit Committee alongside Rene Alexander Acosta and Paula J. Dobriansky. The Board determined Mr. Evans to be independent under New York Stock Exchange rules, with compensation per the Director Compensation Policy and no related arrangements or material transactions disclosed. A press release announcing the appointment was issued on March 23, 2026.

• ·Mr. Evans executed the Company’s standard form of indemnification agreement for directors (previously filed as Exhibit 6.7 to Form 1-A on February 7, 2025).
• ·Information in Item 7.01 and Exhibit 99.1 is furnished, not filed, under Regulation FD.

23-03-2026

California Resources Corporation completed an upsized private offering of an additional $350M aggregate principal amount of 7.000% senior unsecured notes due 2034 on March 23, 2026. The net proceeds, along with cash or borrowings, will fund the redemption of $350M of its 8.250% senior unsecured notes due 2029 at 100% plus applicable premium, expected to close on March 24, 2026. This refinancing lowers the interest rate from 8.25% to 7.00% and extends maturity from 2029 to 2034, with the new notes fungible with the existing $400M issuance under the same indenture.

• ·Notes mature on January 15, 2034, with interest accruing from October 8, 2025, payable semi-annually on January 15 and July 15, commencing July 15, 2026.
• ·Original Indenture dated October 8, 2025; First Supplemental Indenture dated January 16, 2026.
• ·Company may redeem notes starting January 15, 2029, or earlier under certain equity proceeds (up to 40%) or with applicable premium; change of control repurchase at 101%.
• ·Notes guaranteed by existing subsidiaries that guarantee revolving credit facility and 2029 Notes.

23-03-2026

Aptose Biosciences Inc. entered into the First Amendment to the Second Amended and Restated Employment Agreement of Dr. William Rice, its Chairman, President, and CEO, effective March 12, 2026. The amendment confirms that no deferred compensation plan was created, no deferred compensation was earned, and no such benefits are owed to Dr. Rice. It also establishes that Dr. Rice is solely responsible for any potential individual taxes, penalties, and interest on benefits paid or payable under the original agreement dated April 29, 2024.

23-03-2026

FG Nexus Inc. completed the sale of its FG Reinsurance Division (FG Re and FG Solutions) to Devondale Holdings, LLC on March 23, 2026, with the final $1M cash payment received by subsidiary FGRH. The total consideration includes the release of $3.3M in collateral, 40% of Devondale's Class A voting units, and a $1.25M promissory note at 6% interest due June 30, 2027. No negative impacts or performance declines were reported in the filing.

• ·Transaction Agreement initially dated June 27, 2025, executed October 22, 2025; First Closing on January 2, 2025; Assignment by Thomas Heise on September 16, 2025; Letter agreement dated October 25, 2025.
• ·Devondale funded $1M payment via loan from Saltire Capital Ltd. subsidiary, receiving in exchange a $1M promissory note and 40% of Devondale's Class A voting units.

23-03-2026

Oil States International, Inc. announced the retirement of President and CEO Cindy Taylor effective May 1, 2026, with Executive Vice President, CFO, and Treasurer Lloyd Hajdik succeeding her as President and CEO and joining the Board. Matthew E. Autenrieth will be appointed as the new Executive Vice President, CFO, and Treasurer effective the same date. Taylor will remain in a consulting role through October 31, 2026, supporting a seamless transition amid the company's strong position with a clean balance sheet, little to no debt, and record backlog.

• ·Cindy Taylor has over 25 years of service to Oil States, including 19 years as CEO.
• ·Lloyd Hajdik joined Oil States in December 2013; served as Senior VP, CFO from Dec 2013 to May 2016, then EVP, CFO since May 2016.
• ·Matthew E. Autenrieth joined Oil States in December 2007.
• ·Oil States provides manufactured products and services to energy, military, and industrial sectors.